Related Experiment Video

Updated: Mar 15, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.1K

A community-based model of rapid autopsy in end-stage cancer patients

Kathryn Alsop1, Heather Thorne1,2, Shahneen Sandhu3

  • 1Cancer Genomics Program, Research Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Nature Biotechnology
|September 13, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.6K
Large-Animal Model of Donation after Circulatory Death and Normothermic Regional Perfusion for Cardiac Assessment
07:49

Large-Animal Model of Donation after Circulatory Death and Normothermic Regional Perfusion for Cardiac Assessment

Published on: May 10, 2022

2.1K

Related Experiment Videos

Last Updated: Mar 15, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.1K
A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.6K
Large-Animal Model of Donation after Circulatory Death and Normothermic Regional Perfusion for Cardiac Assessment
07:49

Large-Animal Model of Donation after Circulatory Death and Normothermic Regional Perfusion for Cardiac Assessment

Published on: May 10, 2022

2.1K

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

811
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
811

Articles linked to this work by shared authors, journal, and citation graph.

Real-World Experience of Cabozantinib in Relapsed Osteosarcoma and Ewing Sarcoma-A Single Center Retrospective Study.

Asia-Pacific journal of clinical oncology·2026

Integrated signatures define mutational processes in prostate cancer.

Nature·2026

Recurrent mechanisms of biallelic epigenetic inactivation reveal new putative tumour suppressor genes in prostate cancer.

Nature communications·2026

Dual plasmepsin IX and X inhibitors are refractory to development of resistance.

PLoS pathogens·2026

Rilvegostomig for Metastatic Non-Small-Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Using polygenic risk scores to refine risk and outcomes in high-grade serous ovarian cancer in Australia.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026

An engineered nanopore identifies saccharides, amino acids, peptides and ribonucleotides.

Nature biotechnology·2026

Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment.

Nature biotechnology·2026

Engineered genomic attachment sites for site-specific recombinases enable high-efficiency integration in plants and human cells.

Nature biotechnology·2026

AI-enhanced adaptive virtual screening of large libraries for ligand discovery.

Nature biotechnology·2026

A pervasive RT-qPCR artifact inflates RNA knockdown by RNA-targeting CRISPR.

Nature biotechnology·2026

Macropinocytosis-mediated recyclable LYTACs (McR-TACs) for receptor-independent protein degradation.

Nature biotechnology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us